
A rare-disease platform that uses precomputed multilevel biological representations to power two world models: one generates personalized mechanistic disease hypotheses, the other designs patient-specific AAV therapeutics. Pareto frontiers balance biologist intuition with machine-learning exploration. The demo focused on Duchenne muscular dystrophy.
Sign in to leave a comment.
No comments yet.